National Center of Regenerative Medicine-Stem Cell Pilot
- Current funds for this program come from the April 2009 award from the Research Commercialization Program (RCP) of $5 million which includes $200,000 annual funding for pilot projects. Additional funds from the Case Western Reserve University Clinical and Translational Science Collaborative (CTSC) for Core Utilization Pilot Awards will be added to leverage and promote new projects in stem cell translational research.
The National Center of Regenerative Medicine (NCRM) is composed of investigators from Case Western Reserve University (CWRU), University Hospitals Case Medical Center (UHCMC), Cleveland Clinic (CC), Athersys Inc., and Ohio State University. NCRM's mission is to rapidly translate cutting-edge adult-derived stem cell technology into the clinic and commercial arenas. Currently ten different non-embryonic and two pluripotent stem cell types are being investigated in a range of therapeutic areas including cancer, musculoskeletal, orthopedic, cardiovascular, hematopoietic and neurodegenerative disorders.
Applications should be submitted through Webgrants at http://webgrants.case.edu/.
Regenerative Medicine RFA available when active